Oxidative stress and inflammatory response in patients with psoriasis; is there any relationship with psychiatric comorbidity and cognitive functions?

References

• Ebling CEMGWW. Text book of dermatology. Last ed. London: Blackwell Science; 2004.
   Google Scholar
• Krishnamurthy K, Walker A, Gropper CA, et al. To treat or not to treat? management of guttate psoriasis and pityriasis rosea in patients with evidence of group A streptococcal infection. J Drugs Dermatol. 2010;9(3):241–250.
   Web of Science ®Google Scholar
• Griffiths C, Christophers E, Barker J, et al. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol. 2007;156(2):258–262.
   PubMed Web of Science ®Google Scholar
• Meier M, Sheth PB. Clinical spectrum and severity of psoriasis.
   Google Scholar
• Naldi L, Chatenoud L, Linder D, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian Case–control study. J Investig Dermatol. 2005;125(1):61–67.
   PubMed Web of Science ®Google Scholar
• Sagoo GS, Tazi-Ahnini R, Barker JWN, et al. Meta-analysis of genome-wide studies of psoriasis susceptibility reveals linkage to chromosomes 6p21 and 4q28–q31 in Caucasian and Chinese Hans population. J Investig Dermatol. 2004;122(6):1401–1405.
   Web of Science ®Google Scholar
• Gurer MA, Adisen E. Venerology. Psoriasis, introduction, general information, epidemiology/Psoriasis, genel bilgiler, epidemiyoloji. 2008: 15–18.
   Google Scholar
• Aydemir EHYSM. Psoriasiste Psikosomatik Faktörler, Psikolojik Durum ve Psoriasisli Hastaya Yaklaşım. Türkderm. 2008;42:2–29.
   Google Scholar
• Tribó MJ, Turroja M, Castaño-Vinyals G, et al. Patients with moderate to severe psoriasis associate with higher risk of depression and anxiety symptoms: results of a multivariate study of 300 Spanish individuals with psoriasis. Acta Derm Venereol. 2019. DOI:10.2340/00015555-3114
   Web of Science ®Google Scholar
• Tüzün Y, Gürer MA, Serdaroğlu S, Oğuz O, Aksungur VL Dermatoloji. İstanbul: Nobel Tıp Kitabevleri; 2008.
   Google Scholar
• Das K, Rao T, Sciences A. Psychosomatic interface: psychological distress and perceived stress in psoriasis patients in a tertiary care hospital in South India. Open J Psychiatry Allied Sci. 2018;9(2):123–129.
   Google Scholar
• Feldman SR, Koo J, Marangell LB. Epidemiology of mental health comorbidity in psoriasis AU - Wu, J. J. J Dermatol Treatment. 2018;29(5):487–495.
   Web of Science ®Google Scholar
• Fortune DG, Richards HL, Griffiths CEJDC. Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol Clin. 2005;23(4):681–694.
   PubMed Web of Science ®Google Scholar
• Bickers DR, Athar M. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol. 2006;126(12):2565–2575.
   PubMed Web of Science ®Google Scholar
• Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood. 1998;92(9):3007–3017.
   PubMed Web of Science ®Google Scholar
• Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem. 1995;41(12 Pt 2):1819–1828.
   PubMed Web of Science ®Google Scholar
• Kadam DP, Suryakar AN, Ankush RD, et al. Role of oxidative stress in various stages of psoriasis. Indian J Clin Biochem. 2010;25(4):388–392.
   PubMedGoogle Scholar
• Kaur S, Zilmer K, Leping V, et al. Serum methylglyoxal level and its association with oxidative stress and disease severity in patients with psoriasis. Arch Dermatol Res. 2013;305(6):489–494.
   PubMed Web of Science ®Google Scholar
• Emre S, Metin A, Demirseren DD, et al. The relationship between oxidative stress, smoking and the clinical severity of psoriasis. J Eur Acad Dermatol Venereol. 2013;27(3):e370–e375.
   PubMed Web of Science ®Google Scholar
• Rocha-Pereira P, Santos-Silva A, Rebelo I, et al. Erythrocyte damage in mild and severe psoriasis. Br J Dermatol. 2004;150(2):232–244.
   PubMed Web of Science ®Google Scholar
• Ferreira BIRC, Abreu JLPDC, Dos Reis JPG. Figueiredo AMDCJTJoc, dermatology a. Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation. J Clin Aesthet Dermatol. 2016;9(6):36.
   PubMedGoogle Scholar
• de Brouwer SJ, van Middendorp H, Stormink C, et al. Immune responses to stress in rheumatoid arthritis and psoriasis. Rheumatology. 2014;53(10):1844–1848.
   Web of Science ®Google Scholar
• Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(2):201–217.
   PubMed Web of Science ®Google Scholar
• Lindqvist D, Dhabhar FS, James SJ, et al. Oxidative stress, inflammation and treatment response in major depression. Psychoneuroendocrinology. 2017;76:197–205.
   PubMed Web of Science ®Google Scholar
• Black CN, Bot M, Scheffer PG, et al. Is depression associated with increased oxidative stress? A systematic review and meta-analysis. Psychoneuroendocrinology. 2015;51:164–175.
   PubMed Web of Science ®Google Scholar
• Chiurchiu V, Maccarrone M. Chronic inflammatory disorders and their redox control: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2011;15(9):2605–2641.
   Web of Science ®Google Scholar
• Capuron L, Fornwalt FB, Knight BT, et al. Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? J Affect Disord. 2009;119(1–3):181–185.
   PubMed Web of Science ®Google Scholar
• Colgecen E, Celikbilek A, Keskin D. Cognitive impairment in patients with psoriasis: a cross-sectional study using the Montreal cognitive assessment. Am J Clin Dermatol. 2016;17(4):413–419.
   PubMed Web of Science ®Google Scholar
• Maes M, Yirmyia R, Noraberg J, et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis. 2009;24(1):27–53.
   PubMed Web of Science ®Google Scholar
• Yan MH, Wang X, Zhu X. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic Biol Med. 2013;62:90–101.
   PubMed Web of Science ®Google Scholar
• Tonnies E, Trushina E. Oxidative stress, synaptic dysfunction, and Alzheimer's disease. J Alzheimer's Dis. 2017;57(4):1105–1121.
   PubMed Web of Science ®Google Scholar
• González-Parra S, Daudén E. Psoriasis y depresión: el papel de la inflamación. Actas Dermo-Sifiliográficas. 2019;110(1):12–19.
   PubMed Web of Science ®Google Scholar
• Lim DS, Bewley A, Oon HH. Psychological Profile of patients with psoriasis. Ann Acad Med Singap. 2018;47(12):516–522.
   PubMed Web of Science ®Google Scholar
• Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571.
   PubMed Web of Science ®Google Scholar
• Beck NH. Depresyon Envanterinin üniversite öğrencileri için geçerliği, güvenirliği. Psikoloji Dergisi. 1989;7(23):3–13.
   Google Scholar
• Beck AT, Epstein N, Brown G, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893–897.
   PubMed Web of Science ®Google Scholar
• Beck MU. Anxiety inventory: Validity and reliability study. Unpublished specialization in medicine thesis. Bakırköy Mental and Neurological Diseases Hospital, Istanbul. 1993.
   Google Scholar
• Newcombe F. Missile wounds of the brain: a study of psychological deficits. Oxford: Oxford University Press; 1969.
   Google Scholar
• Tumaç A. Normal deneklerde frontal hasarlara duyarlı bazı testlerde performansa yaş ve eğitimin etkisi. İstanbul: İstanbul Üniversitesi; 1997.
   Google Scholar
• Rey A. L’examen clinique en psychologie [The clinical psychological examination]. Paris: Presses universitaires de France; 1964.
   Google Scholar
• Oktem O. Sozel bellek surecleri testi (bir on calisma). Noropsikiyatri arsivi. 1992;29(4):196–206.
   Google Scholar
• Brown J. Some tests of the decay theory of immediate memory. Q J Exp Psychol. 1958;10(1):12–21.
   Web of Science ®Google Scholar
• Peterson LR, Peterson MJ. Short-term retention of individual verbal items. J Exp Psychol. 1959;58:193–198.
   PubMedGoogle Scholar
• Anil AE, Kivircik BB, Batur S, et al. The Turkish version of the Auditory Consonant Trigram test as a measure of working memory: a normative study. Clin Neuropsychol. 2003;17(2):159–169.
   PubMed Web of Science ®Google Scholar
• Heaton RK. A manual for the Wisconsin card sorting test. Odessa: Western Psycological Services; 1981.
   Google Scholar
• Heaton RK. Wisconsin card sorting test: computer version 2. Odessa: Psychological Assessment Resources; 1993.
   Google Scholar
• Heaton R CG, Talley JL, Kay G, et al. Wisconsin card sorting test manual: revised and expanded. Odessa: Psychological Assessment Resources. Inc; 1993.
   Google Scholar
• Tchanturia K, Davies H, Roberts M, et al. Poor cognitive flexibility in eating disorders: examining the evidence using the Wisconsin Card Sorting Task. PLOS ONE. 2012;7(1):e28331.
   PubMed Web of Science ®Google Scholar
• Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37(2):112–119.
   PubMed Web of Science ®Google Scholar
• Romay C, Pascual C, Lissi EA. The reaction between ABTS radical cation and antioxidants and its use to evaluate the antioxidant status of serum samples. Braz J Med Biol Res. 1996;29(2):175–183.
   Web of Science ®Google Scholar
• Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103–1111.
   PubMed Web of Science ®Google Scholar
• Harma M, Harma M, Kocyigit A, et al. Increased DNA damage in patients with complete hydatidiform mole. Mutat Res. 2005;583(1):49–54.
   Web of Science ®Google Scholar
• Rocha-Pereira P, Santos-Silva A, Rebelo I, et al. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta. 2001;303(1–2):33–39.
   PubMed Web of Science ®Google Scholar
• Karababa F, Yesilova Y, Turan E, et al. Impact of depressive symptoms on oxidative stress in patients with psoriasis. Redox Rep. 2013;18(2):51–55.
   PubMed Web of Science ®Google Scholar
• van de Kerkhof PC. The evolution of the psoriatic lesion. Br J Dermatol. 2007;157(1):4–15.
   Web of Science ®Google Scholar
• Kemmett D, Symons JA, Colver GB, et al. Serum-soluble interleukin 2 receptor in psoriasis. Failure to reflect clinical improvement. Acta Derm Venereol. 1990;70(3):264–266.
   Web of Science ®Google Scholar
• Kim J, Krueger JG. The immunopathogenesis of psoriasis. Dermatol Clin. 2015;33(1):13–23.
   PubMed Web of Science ®Google Scholar
• Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46–56.
   PubMed Web of Science ®Google Scholar
• Kupper N, Widdershoven JW, Pedersen SS. Cognitive/affective and somatic/affective symptom dimensions of depression are associated with current and future inflammation in heart failure patients. J Affect Disord. 2012;136(3):567–576.
   Web of Science ®Google Scholar
• Bettcher BM, Kramer JH. Longitudinal inflammation, cognitive decline, and Alzheimer's disease: a mini-review. Clin Pharmacol Ther. 2014;96(4):464–469.
   PubMed Web of Science ®Google Scholar
• Tan ZS, Beiser AS, Vasan RS, et al. Inflammatory markers and the risk of Alzheimer disease: the Framingham study. Neurology. 2007;68(22):1902–1908.
   PubMed Web of Science ®Google Scholar
• Holmes C, Cunningham C, Zotova E, et al. Systemic inflammation and disease progression in Alzheimer disease. Neurology. 2009;73(10):768–774.
   PubMed Web of Science ®Google Scholar
• Eikelenboom P, Hoozemans JJ, Veerhuis R, et al. Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer's disease. Alzheimers Res Ther. 2012;4(3):15.
   Web of Science ®Google Scholar
• Wersching H, Duning T, Lohmann H, et al. Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function. Neurology. 2010;74(13):1022–1029.
   PubMed Web of Science ®Google Scholar
• Campalani E, Allen MH, Fairhurst D, et al. Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin. Br J Dermatol. 2006;154(2):345–352.
   Web of Science ®Google Scholar
• Yu JT, Tan L, Hardy J. Apolipoprotein E in Alzheimer's disease: an update. Annu Rev Neurosci. 2014;37:79–100.
   PubMed Web of Science ®Google Scholar
• Saraceno R, Kleyn CE, Terenghi G, et al. The role of neuropeptides in psoriasis. Br J Dermatol. 2006;155(5):876–882.
   Web of Science ®Google Scholar
• Brunoni AR, Santos IS, Sabbag C, et al. Psoriasis severity and hypothalamic-pituitary-adrenal axis function: results from the CALIPSO study. Braz J Med Biol Res. 2014;47(12):1102–1106.
   Web of Science ®Google Scholar
• Brunoni AR, Lopes M, Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacology. 2008;11(8):1169–1180.
   PubMed Web of Science ®Google Scholar
• Bath KG, Schilit A, Lee FS. Stress effects on BDNF expression: effects of age, sex, and form of stress. Neuroscience. 2013;239:149–156.
   PubMed Web of Science ®Google Scholar
• Panza F, Frisardi V, Seripa D, et al. Metabolic syndrome, mild cognitive impairment, and dementia. Curr Alzheimer Res. 2011;8(5):492–509.
   PubMed Web of Science ®Google Scholar
• Gisondi P, Sala F, Alessandrini F, et al. Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis. Dermatology (Basel, Switzerland). 2014;228(1):78–85.
   Web of Science ®Google Scholar
• Marek-Jozefowicz L, Jaracz M, Placek W, et al. Cognitive impairment in patients with severe psoriasis. Postepy Dermatol Alergol. 2017;34(2):120–125.
   Web of Science ®Google Scholar
• Pezzolo E, Mutlu U, Vernooij MW, et al. Psoriasis is not associated with cognition, brain imaging markers and risk of dementia: the Rotterdam study. J Am Acad Dermatol. 2018. DOI:10.1016/j.jaad.2018.07.046
   Google Scholar
• Godbout JP, Johnson RW. Interleukin-6 in the aging brain. J Neuroimmunology. 2004;147(1–2):141–4.
   Web of Science ®Google Scholar
• Yirmiya R, Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun. 2011;25(2):181–213.
   PubMed Web of Science ®Google Scholar
• D'Arcangelo G, Tancredi V, Onofri F, et al. Interleukin-6 inhibits neurotransmitter release and the spread of excitation in the rat cerebral cortex. Eur J Neurosci. 2000;12(4):1241–1252.
   PubMed Web of Science ®Google Scholar
• Vallieres L, Campbell IL, Gage FH, et al. Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J Neurosci. 2002;22(2):486–492.
   PubMed Web of Science ®Google Scholar
• Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. Science. 2003;302(5651):1760–1765.
   PubMed Web of Science ®Google Scholar
• Matsuda S, Wen TC, Morita F, et al. Interleukin-6 prevents ischemia-induced learning disability and neuronal and synaptic loss in gerbils. Neurosci Lett. 1996;204(1–2):109–112.
   Web of Science ®Google Scholar
• Bermejo P, Martin-Aragon S, Benedi J, et al. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease. Immunol Lett. 2008;117(2):198–202.
   PubMed Web of Science ®Google Scholar
• Cojocaru IM, Cojocaru M, Miu G, et al. Study of interleukin-6 production in Alzheimer's disease. Roman J Intern Med. 2011;49(1):55–58.
   Google Scholar
• Hampel H, Haslinger A, Scheloske M, et al. Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain. Eur Arch Psychiatry Clin Neurosci. 2005;255(4):269–278.
   Web of Science ®Google Scholar
• Huell M, Strauss S, Volk B, et al. Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients. Acta Neuropathol. 1995;89(6):544–551.
   PubMed Web of Science ®Google Scholar
• Luterman JD, Haroutunian V, Yemul S, et al. Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Arch Neurol. 2000;57(8):1153–1160.
   Google Scholar
• Erickson MA, Dohi K, Banks WA. Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier. Neuroimmunomodulation. 2012;19(2):121–130.
   PubMed Web of Science ®Google Scholar
• Douglas KM, Porter RJ. Longitudinal assessment of neuropsychological function in major depression. Aust N Z J Psychiatry. 2009;43(12):1105–1117.
   PubMed Web of Science ®Google Scholar
• Duman RS. Depression: a case of neuronal life and death? Biol Psychiatry. 2004;56(3):140–145.
   PubMed Web of Science ®Google Scholar
• Grassi-Oliveira R, Brietzke E, Pezzi JC, et al. Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder. Psychiatry Clin Neurosci. 2009;63(2):202–208.
   Web of Science ®Google Scholar
• Tyring S, Gottlieb A, Papp K, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet. 2006;367(9504):29–35.
   PubMed Web of Science ®Google Scholar
• Raison CL, Rutherford RE, Woolwine BJ, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. 2013;70(1):31–41.
   Google Scholar
• Jin W, Zhang S, Duan Y. Depression symptoms Predict worse clinical response to etanercept treatment in psoriasis patients Dermatology. JAMA Psychiat. 2019;235(1):55–64.
   Google Scholar